BackSio Gene Therapies Overview

Sio Gene Therapies Intangible Assets

Latest intangible assets for SIOX: $0.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00

Peer average

Loading

Sio Gene Therapies Intangible Assets History

Loading

Sio Gene Therapies vs. peers: Intangible Assets Comparison

Loading

Sio Gene Therapies Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sio Gene Therapies (SIOX) FAQ

Sio Gene Therapies (SIOX) currently reports a intangible assets of $0 as of December 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Sio Gene Therapies's intangible assets history and peer comparisons.

Sio Gene Therapies's intangible assets changed from $0 to $0 (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sio Gene Therapies reported $0 in intangible assets as of December 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sio Gene Therapies, and consider following SIOX for alerts when major investors trade the stock.

Sio Gene Therapies is classified in the Healthcare sector. On intangible assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SIOX with unrelated industries.